MUSC Cancer Researcher To Present Breast Surgery Findings
Posted on: Monday, 25 September 2006, 12:01 CDT
CHARLESTON, S.C., Sept. 25 /PRNewswire/ -- A time-compressed breast cancer treatment being used by the Hollings Cancer Center at the Medical University of South Carolina results in excellent cosmetic outcome for most women undergoing the treatment, said Anthony E. Dragun, M.D., who will be presenting his research findings Nov. 4 at the 48th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Philadelphia, Pa.
MUSC began using the innovative therapy called MammoSite breast brachytherapy in 2002 and was one of the first hospitals in the nation to use the technique after its approval by the Food and Drug Administration. As a result, MUSC has accumulated one of the largest databases of MammoSite patients with some of the longest follow-ups.
Dragun, chief resident in MUSC's Department of Radiation Oncology, said that MammoSite is used to deliver radiation therapy following a lumpectomy for early-stage breast cancer. A major advantage of MammoSite is that it reduces the time frame for post-surgical radiation therapy from six weeks to just five days.
Surgeons place the MammoSite device in a separate procedure after a lumpectomy. Radiation oncologists then use the device to guide radiation only to that breast tissue, which is the highest risk for cancer recurrence, sparing the remaining breast tissue from further radiation.
The cosmetic issues that normally stem from traditional radiation therapy include painful redness and peeling of the breast skin. However, MammoSite virtually eliminates these complications. Dragun's study shows that the majority of patients treated with MammoSite have an excellent cosmetic outcome. In his study, Dragun also found that complications resulting in fair to poor cosmetic outcomes have dropped significantly since the device was first introduced.
Dragun's study, titled "Predictors of Cosmetic Outcome Following MammoSite Breast Brachytherapy," was chosen from a record-breaking 1,640 abstracts submitted for review to be presented at the ASTRO meeting, which is the largest gathering of radiation oncology specialists in the world. ASTRO is the largest radiation oncology society in the world, with more than 8,500 members who specialize in treating patients with radiation therapy.
For more information, contact Dr. Dragun at dragun@radonc.musc.edu or (843) 792-3271.
For more information on ASTRO's 48th Annual Meeting, visit http://www.astro.org/annual_meeting/.
Medical University of South Carolina
CONTACT: Kate Watson for Medical University of South Carolina,+1-843-792-1247
Web site: http://www.musc.edu/http://www.astro.org/annual_meeting
Source: PRNewswire
Related Articles
- Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
- Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
- Nuvera Biosciences Presents Advances in Breast Cancer Genomic Assays at ASCO Annual Meeting
- ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
- Increasing Disease Prevalence and Emergence of Novel Therapies Will Drive 5% Annual Growth in Type 2 Diabetes Drug Market Through 2016
- Imaging Diagnostic Systems' Director of Clinical Research Cautions Against Excess Radiation Dose to Breasts
- Two-Year Data Showing Decreases in Suicidality in Patients With Treatment- Resistant Depression Treated With VNS Therapy Presented at Annual American Psychiatric Association Meeting
- Two-Year Data Showing Unprecedented Durability of Antidepressant Response in TRD Patients Treated With VNS Therapy Presented at Annual American Psychiatric Association Meeting
- Protection of Normal Tissue From Radiation-Induced Injury Using AEOL 10150 Presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology
- New One-Week Radiation Treatment for Breast Cancer Patients OffersPromising Results
 |
 |
User Comments (0)
RSS Feeds